VYNE Therapeutics
VYNE
VYNE
48 hedge funds and large institutions have $116M invested in VYNE Therapeutics in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
80% less capital invested
Capital invested by funds: $579M → $116M (-$463M)
Holders
48
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.53M | |
| 2 | +$1.74M | |
| 3 | +$609K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$479K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$406K |
Top Sellers
| 1 | -$16M | |
| 2 | -$12.8M | |
| 3 | -$12.7M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.52M |
| 5 |
PA
Perceptive Advisors
New York
|
-$2.9M |